LENS initiatives highlighted in CERN Courier
27 APR 2020
The CERN Courier has published a policy piece by LENS Chair Helmut Schober, Director of Institut Laue-Langevin (ILL), that highlights the enormous potential for growth in Europe’s world-leading neutron science ecosystem.
The essay emphasises the essential contributions neutrons will make at each stage of the innovation chain that will drive the coming green wave of technological development in Europe.
In spite of last year’s closures of research reactors in France, Germany and Norway that have set back Europe’s neutron capacity, Schober is optimistic about the future of neutron science. In the essay, he sketches out the necessary components for a healthy future that include:
- Securing the scientific, technical and economic futures of ILL, the UK’s ISIS Neutron & Muon Source and the FRM-II reactor at Munich’s Heinz-Maier Leibnitz centre for neutron research;
- ensuring the rapid ramp-up of operations at the European Spallation Source;
- and developing the compact accelerator-based neutron source (CANS) initiatives at CEA-Saclay and the Jülich Centre for Neutron Science.
Recent News & Events
- From 15 - 19 February 2021, over 80 participants attended the online LENS Machine Learning School. The school, which was targeted towards neutron and muon facilities staff, offered a gateway for beginner and intermediate coders to get into machine learning, providing an overview of modern and traditional machine learning techniques alongside neutron or muon based applications.
- Register for the RI.Logistica conference today and be part of an unparalleled international forum that will impact how research infrastructures deal with logistics in the future.
- LENS Webinar #10 on ‘Drug development and drug delivery systems ‘ with Andrey Kovalevski (ORNL) & Marianna Yanez Arteta (AstraZeneca Mölndal)This webinar will focus on how neutrons can provide crucial information to study the structure-dynamics-function relationships in macromolecular drug targets and to design successful drug delivery systems.